# RIC3

## Overview
RIC3 is a gene that encodes the RIC3 acetylcholine receptor chaperone, a protein primarily involved in the folding and assembly of nicotinic acetylcholine receptors (nAChRs), particularly the α7 subtype, within the endoplasmic reticulum (ER) of cells. The RIC3 protein is categorized as a type II transmembrane protein and functions as an intrinsically disordered chaperone, facilitating the maturation and surface expression of nAChRs, which are crucial for synaptic transmission and neuromuscular communication (Crespi2017Proteins; Dau2013RIC3). The gene's expression and the protein's activity are tightly regulated, as imbalances can lead to receptor retention in the ER or altered receptor expression, impacting cellular communication (Crespi2017Proteins). RIC3 has significant clinical implications, with its expression linked to various neuroinflammatory and neurodegenerative diseases, including multiple sclerosis and Parkinson's disease, highlighting its importance in maintaining neuronal health and function (Mizrachi2021Neuroinflammation; BenDavid2020RIC3).

## Structure
The RIC3 protein is an intrinsically disordered, endoplasmic reticulum (ER)-resident chaperone involved in the folding and assembly of α7 nicotinic acetylcholine receptors (nAChRs) (Loring2022Speculation). Its primary structure includes several key domains: an initial transmembrane domain (TM) that may function as a signal peptide, a second putative transmembrane domain (TMD), a cytoplasmic linker, at least one coiled-coil domain, and a highly variable C-terminal tail (Loring2022Speculation). The N-terminal region contains two hydrophobic segments linked by a proline-rich linker, while the C-terminal region includes coiled-coil motifs (Pradhan2024Unraveling).

The secondary structure of RIC3 is characterized by alpha helices, particularly in the signal sequences, TMs, and coiled-coil domains, although other regions show less structural certainty (Loring2022Speculation). The tertiary structure is not fully detailed, but the protein's flexible regions, rich in glycine, alanine, and serine, suggest a dynamic conformation (Loring2022Speculation).

RIC3 is a type II transmembrane protein, with its N-terminus located in the cytoplasm and the C-terminus in the ER lumen (Pradhan2024Unraveling). Splice variants of RIC3, such as RIC-3e, lack the coiled-coil domain and part of the C-terminal sequence, resulting in different functional properties (Seredenina2008Molecular). These structural features are crucial for RIC3's role in facilitating the assembly and trafficking of α7 nAChRs.

## Function
RIC3 is a chaperone protein that plays a critical role in the folding, assembly, and functional expression of nicotinic acetylcholine receptors (nAChRs), particularly the α7 subtype, in the endoplasmic reticulum (ER) of healthy human cells. It facilitates the maturation and surface expression of these receptors, which are essential for synaptic transmission and neuromuscular communication (Crespi2017Proteins; Dau2013RIC3). RIC3 enhances the assembly of α7 nAChRs by increasing the proximity of receptor subunits, as evidenced by increased FRET efficiencies, and promotes their transport to the cell surface, which is necessary for their exit from the ER and progression along the secretory pathway (Dau2013RIC3).

RIC3's function is highly dependent on its expression levels; while it generally aids in receptor assembly, excessive amounts can lead to retention of nAChRs in the ER due to RIC3 oligomerization (Crespi2017Proteins). The protein's activity is also cell type-dependent, with some cell lines showing high surface receptor levels and others showing none, indicating that other chaperones may also be involved in receptor expression (Crespi2017Proteins). RIC3's role in receptor assembly and trafficking is crucial for maintaining proper receptor function in healthy human cells (Seredenina2008Molecular).

## Clinical Significance
The RIC3 gene, encoding the RIC-3 protein, is implicated in several neuroinflammatory and neurodegenerative diseases due to its role as a chaperone for nicotinic acetylcholine receptors (nAChRs), particularly the α7 subtype. Alterations in RIC3 expression have been associated with multiple sclerosis (MS), where increased expression of RIC3 and CHRNA7 has been observed in some patients, suggesting a compensatory mechanism to reduce inflammation (Mizrachi2021Neuroinflammation; BenDavid2020RIC3). Genome-wide association studies have linked RIC3 to MS, indicating that genetic variants may influence the disease by affecting α7 nAChR maturation in immune cells (Mizrachi2021Neuroinflammation).

RIC3 expression is also dynamically regulated in response to immune activation, with reductions observed in experimental autoimmune encephalomyelitis (EAE), a model for MS, and in human immune cells following activation (BenDavid2020RIC3). Beyond MS, RIC3 has been implicated in other conditions such as bipolar disorder, Parkinson's disease, and cognitive decline in the elderly (BenDavid2020RIC3). Mutations in the RIC3 gene have been found in Parkinson's disease patients, further highlighting its clinical significance in neurodegenerative disorders (Mizrachi2021Neuroinflammation).

## Interactions
RIC3 interacts with various nicotinic acetylcholine receptor (nAChR) subunits, playing a crucial role in their assembly and expression. It specifically enhances the assembly and surface expression of α7 nAChRs by facilitating their proper folding and maturation. This interaction is dose-dependent, with optimal assembly observed at a 1:1 ratio of RIC3 to α7 subunits. However, excessive RIC3 can lead to aggregation, hindering the trafficking of α7 receptors to the cell surface (Dau2013RIC3).

For α4β2 nAChRs, RIC3 does not significantly alter assembly but increases the expression of α4 and β2 subunits, potentially enhancing nicotinic responses. RIC3 interacts with β2 subunits optimally at a 0.5:1 molar ratio, indicating a specific stoichiometry for effective interaction (Dau2013RIC3).

RIC3's role extends to modulating receptor responses to nicotine. It prevents nicotine-induced upregulation of α4β2 receptor assembly, although it still increases the protein expression of these subunits. This suggests that RIC3 may inhibit degradation signals and promote forward trafficking, similar to other chaperones like 14-3-3 (Dau2013RIC3).


## References


[1. (BenDavid2020RIC3) Yael Ben-David, Sara Kagan, Hagit Cohen Ben-Ami, Jinar Rostami, Tehila Mizrahi, Abhijit R. Kulkarni, Ganesh A. Thakur, Adi Vaknin-Dembinsky, Luke M. Healy, Talma Brenner, and Millet Treinin. Ric3, the cholinergic anti-inflammatory pathway, and neuroinflammation. International Immunopharmacology, 83:106381, June 2020. URL: http://dx.doi.org/10.1016/j.intimp.2020.106381, doi:10.1016/j.intimp.2020.106381. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.intimp.2020.106381)

[2. (Pradhan2024Unraveling) Aditi Pradhan, Hayley Mounford, Jessica Peixinho, Edward Rea, Emmanouela Epeslidou, Julia S. Scott, Joanna Cull, Susan Maxwell, Richard Webster, David Beeson, Yin Yao Dong, Stefan Prekovic, Isabel Bermudez, and Dianne F. Newbury. Unraveling the molecular interactions between α7 nicotinic receptor and a ric3 variant associated with backward speech. Cellular and Molecular Life Sciences, March 2024. URL: http://dx.doi.org/10.1007/s00018-024-05149-8, doi:10.1007/s00018-024-05149-8. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-024-05149-8)

[3. (Loring2022Speculation) Ralph H. Loring. Speculation on how ric-3 and other chaperones facilitate α7 nicotinic receptor folding and assembly. Molecules, 27(14):4527, July 2022. URL: http://dx.doi.org/10.3390/molecules27144527, doi:10.3390/molecules27144527. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules27144527)

[4. (Mizrachi2021Neuroinflammation) Tehila Mizrachi, Adi Vaknin-Dembinsky, Talma Brenner, and Millet Treinin. Neuroinflammation modulation via α7 nicotinic acetylcholine receptor and its chaperone, ric-3. Molecules, 26(20):6139, October 2021. URL: http://dx.doi.org/10.3390/molecules26206139, doi:10.3390/molecules26206139. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules26206139)

[5. (Seredenina2008Molecular) Tamara Seredenina, Teresa Ferraro, Georg C. Terstappen, Andrea Caricasole, and Renza Roncarati. Molecular cloning and characterization of a novel human variant of ric-3, a putative chaperone of nicotinic acetylcholine receptors. Bioscience Reports, 28(6):299–306, October 2008. URL: http://dx.doi.org/10.1042/bsr20080055, doi:10.1042/bsr20080055. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bsr20080055)

[6. (Crespi2017Proteins) Arianna Crespi, Sara Francesca Colombo, and Cecilia Gotti. Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update. British Journal of Pharmacology, 175(11):1869–1879, April 2017. URL: http://dx.doi.org/10.1111/bph.13777, doi:10.1111/bph.13777. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1111/bph.13777)

[7. (Dau2013RIC3) Alejandro Dau, Pragya Komal, Mimi Truong, Geoff Morris, Gareth Evans, and Raad Nashmi. Ric-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation. BMC Neuroscience, April 2013. URL: http://dx.doi.org/10.1186/1471-2202-14-47, doi:10.1186/1471-2202-14-47. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2202-14-47)